Topical calcineurin inhibitors for the treatment of vulvar dermatoses

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 146, Issue 1, 2009, Pages 22-29

  Goldstein, Andrew T ^a   Thaçi, Diamant ^b   Luger, Thomas ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Anogenital lichen sclerosus; Genital lichen planus; Topical calcineurin inhibitors; Vulvar dermatoses; Vulvar lichen simplex chronicus

Indexed keywords

ACLOMETASONE DIPROPIONATE; ANTIFUNGAL AGENT; CALCINEURIN INHIBITOR; CLOBETASOL; CLOBETASOL PROPIONATE; CORTICOSTEROID; DIFLUCORTOLONE VALERATE; MOMETASONE FUROATE; PIMECROLIMUS; TACROLIMUS; UNCLASSIFIED DRUG;

ALLERGIC CONTACT DERMATITIS OF THE VULVA; ANOGENITAL LICHEN SCLEROSUS; APPLICATION SITE BURNING; APPLICATION SITE IRRITATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTACT DERMATITIS; DERMATITIS; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; DYSPAREUNIA; DYSURIA; GENITAL LICHEN PLANUS; HERPES VIRUS INFECTION; HUMAN; HYPERPIGMENTATION; LICHEN PLANUS; LICHEN SCLEROSUS ET ATROPHICUS; PAINFUL DEFECATION; PRIORITY JOURNAL; PRURITUS; REVIEW; SKIN ALLERGY; SKIN IRRITATION; TREATMENT DURATION; TREATMENT OUTCOME; VAGINA CANDIDIASIS; VULVA DISEASE; VULVA PRURITUS; VULVAR LICHEN SIMPLEX CHRONICUS;

EID: 68349137825     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2009.05.026     Document Type: Review

References (31)

1. Grassberger M., Steinhoff M., Schneider D., and Luger T.A. Pimecrolimus-an anti-inflammatory drug targeting the skin. Exp Dermatol 13 (2004) 721-730
2. Hultsch T., Kapp A., and Spergel J. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Dermatology 211 (2005) 174-187
3. Alomar A., Berth-Jones J., Bos J.D., et al. The role of topical calcineurin inhibitors in atopic dermatitis. Br J Dermatol 151 70 (2004) 3-27
4. Hoetzenecker W., Ecker R., Kopp T., Stuetz A., Stingl G., and Elbe-Bürger A. Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis. J Allergy Clin Immunol 115 (2005) 1276-1283
5. Simon D., Vassina E., Yousefi S., Braathen L.R., and Simon H.U. Inflammatory cell numbers and cytokine expression in atopic dermatitis after topical pimecrolimus treatment. Allergy 60 (2005) 944-951
6. Büchau A.S., Schauber J., Hultsch T., Stuetz A., and Gallo R.L. Pimecrolimus enhances TLR2/6-induced expression of antimicrobial peptides in keratinocytes. J Invest Dermatol 128 (2008) 2646-2654
7. Hengge U.R., Ruzicka T., Schwartz R.A., and Cork M.J. Adverse effects of topical glucocorticoids. J Am Acad Dermatol 54 (2006) 1-15
8. Salim A., and Wojnarowska F. Skin diseases affecting the vulva. Curr Obstet Gynaecol 15 (2005) 97-107
9. ACOG Practice Bulletin No. 93. Diagnosis and management of vulvar skin disorders. Obstet Gynecol 2008;111:1243-53.
10. Assmann T., Becker-Wegerich P., Grewe M., Megahed M., and Ruzicka T. Tacrolimus ointment for the treatment of vulvar lichen sclerosus. J Am Acad Dermatol 48 (2003) 935-937
11. Kunstfeld R., Kirnbauer R., Stingl G., and Karlhofer F.M. Successful treatment of vulvar lichen sclerosus with topical tacrolimus. Arch Dermatol 139 (2003) 850-852
12. Böhm M., Frieling U., Luger T.A., and Bonsmann G. Successful treatment of anogenital lichen sclerosus with topical tacrolimus. Arch Dermatol 139 (2003) 922-924
13. Goldstein A.T., Marinoff S.C., and Christopher K. Pimecrolimus for the treatment of vulvar lichen sclerosus in a premenarchal girl. J Pediatr Adolesc Gynecol 17 (2004) 35-37
14. Boms S., Gambichler T., Freitag M., Altmeyer P., and Kreuter A. Pimecrolimus 1% cream for anogenital lichen sclerosus in childhood. BMC Dermatol. 4 (2004) 14 10.1186/1471-5945-4-14
15. Goldstein A.T., Marinoff S.C., and Christopher K. Pimecrolimus for the treatment of vulvar lichen sclerosus: a report of 4 cases. J Reprod Med 49 (2004) 778-780
16. Nissi R., Eriksen H., Risteli J., and Niemimaa M. Pimecrolimus cream 1% in the treatment of lichen sclerosus. Gynecol Obstet Invest 127 (2007) 808-816
17. Hengge U.R., Krause W., Hofmann H., et al. Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Br J Dermatol 155 (2006) 1021-1028
18. Luesley D.M., and Downey G.P. Topical tacrolimus in the management of lichen sclerosus. BJOG 113 (2006) 832-834
19. Virgili A., Lauriola M.M., Mantovani L., and Corazza M. Vulvar lichen sclerosus: 11 women treated with tacrolimus 0.1% ointment. Acta Derm Venereol 87 (2007) 69-72
20. Byrd J.A., Davis M.D., and Rogers R.S. Recalcitrant symptomatic vulvar lichen planus. Arch Dermatol 140 (2004) 715-720
21. Lonsdale-Eccles A.A., and Velangi S. Topical pimecrolimus in the treatment of genital lichen planus: a prospective case series. Br J Dermatol 153 (2005) 390-394
22. Goldstein A.T., Parneix-Spax A., McCormick C.L., and Burrows L.J. Pimecrolimus cream 1% for treatment of vulvar lichen simplex chronicus: an open label, preliminary trial. Gynecol Obstet Invest 64 (2007) 180-186
23. Black R.J. Vulval eczema associated with propolis sensitization from topical therapies treated successfully with pimecrolimus cream. Clin Exp Dermatol 30 (2005) 91-92
24. Sarifakioglu E., and Gumus I.I. Efficacy of topical pimecrolimus in the treatment of chronic vulvar pruritus: a prospective case series-a non-controlled, open-label study. J Dermatol Treat 17 (2006) 276-278
25. Oskay T., Sezer H.K., Genç C., and Kutlay L. Pimecrolimus 1% cream in the treatment of vulvar lichen sclerosus in postmenopausal women. Int J Dermatol 46 (2007) 527-532
26. Bilenchi R., Poggiali S., De Padova L.A., Pisani C., De Paola M., and Fimiani M. Human papillomavirus reactivation following topical tacrolimus therapy of anogenital lichen sclerosus. Br J Dermatol 156 (2007) 405-406
27. Spergel J.M., and Leung D.Y. Safety of topical calcineurin inhibitors in atopic dermatitis: evaluation of the evidence. Curr Allergy Asthma Rep 6 (2006) 270-274
28. Langley R.G.B., Luger T.A., Cork M.J., Schneider D., and Paul C. An update on the safety and tolerability of pimecrolimus cream 1%: evidence from clinical trials and post-marketing surveillance. Dermatology 215 1 (2007) 27-44
29. Gallenkemper G., Rabe E., and Bauer R. Contact sensitization in chronic venous insufficiency: modern wound dressings. Contact Dermatitis 38 (1998) 274-278
30. Bauer A., Geier J., and Elsner P. Allergic contact dermatitis in patients with anogenital complaints. J Reprod Med 45 (2000) 649-665
31. Lübbe J., and Sanchez-Politta S. Propolis, beeswax, and the sensitization potential of topical calcineurin inhibitors. Clin Exp Dermatol 31 (2006) 147-148